---
title: What Should You Know Before Autologous Stem Cell Collection? 21 Questions Patients Ask Most Often
url: "https://www.yyhmedical.com/en/news/autologous-stem-cell-collection-faq-guide"
type: Article
inLanguage: en-US
category: Expert Insights
datePublished: 2026-06-16
---

# What Should You Know Before Autologous Stem Cell Collection? 21 Questions Patients Ask Most Often

> This Q&A walks patients through the full autologous stem cell collection process and answers 21 common questions about mobilization injections, the collection procedure, recovery afterward, and special situations in which collection may need to be delayed or adjusted.

Summary: Designed for patients and families preparing for autologous stem cell transplantation, this article answers 21 frequently asked questions in a practical Q&A format. Topics include managing side effects from stem cell mobilization with G-CSF, diet and daily routine during mobilization, what to expect during the 3-5-hour peripheral blood stem cell collection procedure, how tingling in the hands or feet is managed, how collected stem cells are cryopreserved and how long they can be stored, and how collection plans may be adjusted for older adults, patients with low body weight, impaired kidney function, and other special circumstances. The goal is to help patients understand each step and feel more prepared for treatment.

  

Patients and families preparing for autologous stem cell transplantation often have many questions about stem cell collection: Why is it needed? What happens during the procedure? Will it affect the body?

Autologous stem cell collection is a well-established and generally safe procedure. To help patients feel more prepared, we have put together answers to 21 questions that come up most often, covering mobilization injections, the collection process, recovery afterward, and special considerations.

**Common Questions About Autologous Stem Cell Collection**

**Q1: What is autologous stem cell collection, and why are my own stem cells collected?**

Autologous collection means collecting healthy hematopoietic stem cells from your own blood in advance and storing them at very low temperatures. After high-dose chemotherapy or conditioning treatment, the stem cells are infused back into your body to help the bone marrow restore blood cell production more quickly and reduce the risk of severe bone marrow suppression.

It is commonly used for patients with lymphoma, multiple myeloma, neuroblastoma, and some high-risk or refractory solid tumors when autologous transplantation is part of the treatment plan.

**Q2: Stem cells normally stay in the bone marrow. How are they collected?**

Before collection, your doctor will first mobilize the stem cells. Granulocyte colony-stimulating factor (G-CSF) is usually given by subcutaneous injection for 3-5 days to encourage stem cells to move from the bone marrow into the peripheral blood. Your blood counts and peripheral blood CD34+ cell level will be monitored regularly. Collection can begin once the target level is reached.

**Q3: Are stem cells collected only through the bloodstream? Do I need a bone marrow harvest?**

Peripheral blood collection using an apheresis machine is now generally preferred. Blood circulates through the machine outside the body, the stem cells are separated out, and the remaining blood components are returned to you. A bone marrow harvest under general anesthesia is not routinely needed. If your peripheral veins are not suitable, a central venous catheter may be placed for collection.

![df0bd53d-b695-453d-b009-2ad642b77da1.png](https://gaobo-byh-h5.oss-accelerate.aliyuncs.com/images/20260913/5a2dd78b0791e5b75faea6a29391ccf9_20260913074426.png "5a2dd78b0791e5b75faea6a29391ccf9_20260913074426.png") 

**Q4: What symptoms can mobilization injections cause? Are the side effects serious?**

Common reactions include aching or bone pain in the lower back, pelvis, arms, or legs, fatigue, and a mild fever - often similar to flu-like symptoms. These effects are usually temporary and often resolve within 2-3 days after the medication is stopped. Pain relief can be used if needed. According to the article, mobilization does not cause permanent organ damage or affect fertility. A small number of patients may also experience mild fatigue or reduced appetite.

**Q5: What should I pay attention to with diet and daily routine during mobilization?**

Stay well hydrated, avoid staying up late, avoid strenuous exercise, and eat enough protein. The article recommends drinking more than 2,000 mL of fluids a day and choosing protein-rich foods such as eggs, lean meat, and milk, while keeping meals relatively light and avoiding very greasy or spicy foods. Try to get adequate sleep and avoid vigorous activity or injuries that could lead to bleeding. You do not need to fast.

**Q6: What if not enough stem cells are released after mobilization?**

If the peripheral blood CD34+ cell count remains low, your doctor may add plerixafor to support mobilization and repeat the assessment 1-2 days later before collection.

**Q7: How long does one autologous stem cell collection session take?**

A single collection usually takes about 3-5 hours. You will remain lying down while blood is drawn through an arm vein or femoral vein and processed automatically by the apheresis machine. Most patients reach the target stem cell dose after one or two collection sessions.

**Q8: Can stem cell collection cause major bleeding?**

After the apheresis machine separates the stem cells, the remaining red blood cells and plasma are returned to your body. The procedure itself does not remove large amounts of blood and is not expected to cause anemia or major bleeding. The basic principle is similar to other forms of extracorporeal blood processing.

**Q9: Why do my hands, feet, or lips sometimes tingle during collection? What can be done?**

The anticoagulant citrate used during collection can temporarily lower the calcium level in the blood, causing tingling or numbness around the lips, hands, or feet. Oral calcium taken in small amounts or intravenous calcium can usually relieve the symptoms quickly, and they generally resolve after collection ends.

**Q10: What if my veins are difficult to access?**

If the veins in both arms are not suitable, a central venous catheter may be placed in the internal jugular or subclavian vein before collection. In some cases, radial artery access may be established. These access routes allow blood to flow to and from the collection circuit and can reduce the need for repeated needle sticks.

**Q11: Is stem cell collection painful?**

The experience can feel different at three stages:

1\. Needle insertion: There is usually only a brief sting when the IV needle is inserted, similar to a routine blood draw or infusion. Local anesthetic is used when a central venous catheter is placed. For patients who cannot cooperate with the procedure, intravenous analgesia or anesthesia may be considered.

2\. During the 3-5-hour machine collection: You mainly need to remain lying down, and there is usually no significant pain. Tingling in the hands, feet, or lips may occur because citrate can temporarily lower calcium levels; this usually improves quickly with calcium replacement and is not considered pain.

3\. Bone pain from mobilization is not the same as pain from collection. G-CSF injections may cause aching in the lower back or bones during the mobilization phase, but for many patients this has already eased by the day of collection.

![4d726d1e-568e-46d1-b357-b75ddcfeb591.png](https://gaobo-byh-h5.oss-accelerate.aliyuncs.com/images/20260913/2127a2d0a23be7df3d28302853848cfd_20260913074454.png "2127a2d0a23be7df3d28302853848cfd_20260913074454.png")

**Q12: Do I need to fast on the day of collection? When can I eat or drink?**

No fasting is required. You can eat your usual meals and drink fluids in moderation, while avoiding very heavy or greasy food. Small amounts of water and light snacks may be taken during collection. It is also helpful to empty your bladder before the procedure begins.

**Q13: How long does it take to recover after stem cell collection?**

Bone pain related to mobilization usually improves within 1-3 days, while fatigue often gets better gradually over 3-7 days. Blood counts generally return to baseline in about a week. The collection does not permanently damage the bone marrow's ability to make blood cells, and hematopoietic stem cells can regenerate.

**Q14: How are the collected stem cells stored, and how long can they be kept?**

A cryoprotective agent is added to the collected stem cells, which are then stored in liquid nitrogen at -196°C. They can be kept for years - sometimes more than a decade - and are thawed and infused when it is time for transplantation.

**Q15: If one collection is not enough, will collecting again the next day harm my body?**

If the first collection does not yield enough cells, your doctor may arrange another collection based on your individual situation. A second collection is used to reach the stem cell dose needed for transplantation and generally does not cause significant additional harm to the body.

**Q16: How should I care for bruising or oozing at the needle site after collection?**

Keep firm pressure on the puncture site and the pressure dressing in place for about 3-4 hours, and keep the area dry for 24 hours. A small bruise can be managed with a cold compress. If bleeding or oozing continues, contact the medical team promptly.

**When Stem Cell Collection May Need to Be Delayed: Contraindications and Special Situations**

**Q17: In what situations should stem cell collection be postponed?**

Collection should generally be delayed in patients with severe heart, lung, or kidney failure; an uncontrolled serious infection; an uncorrected coagulation disorder; or an acute active thrombosis. After the underlying problem has been medically optimized, the patient can be reassessed for collection.

**Q18: Can older adults or patients with low body weight undergo stem cell collection?**

Yes. The medical team can individualize the plan after assessing heart and lung function, liver and kidney function, and coagulation status. The amount of blood processed and the duration of collection can be adjusted, and machine settings can be tailored for children or patients with low body weight. Dongguan Taixin Hospital / GoBroad Chunfu Institute of Hematology & Oncology is a member collection center of the China Marrow Donor Program. From the opening of the department in July 2018 through June 2026, the center completed 1,265 hematopoietic stem cell collections. The smallest patient weighed 8.9 kg, and the youngest was 11 months old.

**Special Considerations for Autologous Stem Cell Collection in Patients With Neuroblastoma (NB)**

**Q19: How successful is stem cell collection in patients with neuroblastoma?**

With standardized treatment, the overall collection success rate for high-risk neuroblastoma is reported in the article as above 90%. Mobilization with G-CSF after two or three cycles of standard induction chemotherapy has a reported success rate of 92%-95%. During bone marrow recovery after chemotherapy, large numbers of stem cells enter the bloodstream, and most patients can collect the target dose in one or two sessions. A CD34+ cell dose of at least 2 × 10^6/kg is generally sufficient for a single transplant, while the target for tandem transplantation is at least 5 × 10^6/kg.

Main reasons collection may fail or fall short of the target include:

-   Too many prior cycles of chemotherapy or chemoimmunotherapy, resulting in significant bone marrow injury
    
-   Tumor involvement of the bone marrow or a high level of residual tumor in the marrow
    
-   Bone marrow damage from radiotherapy
    
-   Repeated severe infections
    

For patients with these risk factors, the medical team may consider rescue mobilization with plerixafor after evaluation. The article reports a collection success rate of about 50%-60% after combination mobilization in this setting.

**Q20: What if one round of mobilization does not produce enough cells? What should I know about trying again?**

① If the peripheral blood CD34+ count is low: plerixafor may be added, with an additional collection later the same day or the next day.

② If the total yield from the current round remains insufficient: another collection may be planned after the next cycle of chemotherapy or chemoimmunotherapy.

Collection should be postponed when there is extensive tumor involvement of the bone marrow, within 3 months after radiotherapy, during a severe infection with fever, or when there is significant liver or kidney dysfunction.

**Q21: What laboratory results are checked before collection? (Blood tests and flow-cytometry thresholds)**

1\. Blood count requirements after G-CSF mobilization and before starting apheresis

WBC ≥5.0 × 10^9/L; neutrophils >2.0 × 10^9/L; platelets (PLT) ≥80 × 10^9/L. If the platelet count is too low, the risk of bleeding during collection may be higher and platelet support may be prepared as clinically appropriate. Hemoglobin (Hb) should be >90 g/L, without moderate or severe anemia.

2\. Key factor:

Peripheral blood CD34+ cells measured by flow cytometry. Blood counts are monitored regularly after G-CSF, and a peripheral blood CD34+ level of ≥20 cells/μL is used in the article as a threshold for starting a single-day collection.

Target total dose: a final cryopreserved CD34+ cell dose of ≥2.0 × 10^6/kg is considered adequate; ≥5 × 10^6/kg provides a larger collection and can support tandem transplantation, which is commonly used in neuroblastoma.

3\. Organ function and infection-related requirements

Liver and kidney function: ALT/AST <2 times the upper limit of normal; creatinine and urea within the normal range; no severe hypoalbuminemia. There should be no active bacterial or viral infection, body temperature should be normal, CRP and procalcitonin should be within the expected range, coagulation function should be generally acceptable, and there should be no active bleeding or thrombosis.

4\. Bone marrow status: A repeat bone marrow aspiration is needed before collection to assess measurable residual disease (MRD).

---
Original (HTML):https://www.yyhmedical.com/en/news/autologous-stem-cell-collection-faq-guide
This is a clean Markdown mirror for large language models; the original page is authoritative.